Decoy Therapeutics Inc. (DCOY): R&D Expense
$368.2K
Year ended 2025-12-31
$2.23M
Trailing 12 months to 2026-06-30
-71.5%
3-year compound annual growth
-44.4%
5-year compound annual growth
-29.8%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $368.2K | -52.2% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $770.0K | -89.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $7.17M | -54.7% | 2025-03-21, From 2023-01-01 |
| 2022-12-31 | $15.84M | +85.3% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $8.55M | +23.6% | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $6.91M | +72.0% | 2022-03-25, From 2020-01-01 |
| 2019-12-31 | $4.02M | +212.1% | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | $1.29M | -92.4% | 2020-03-23, From 2018-01-01 |
| 2017-12-31 | $16.99M | -16.6% | 2019-03-06, From 2017-01-01 |
| 2016-12-31 | $20.38M | +59.8% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $12.75M | n/a | 2018-03-07, From 2015-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $368.2K | -52.2% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.51M | -28.6% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $1.72M | -48.0% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $6.80M | -68.4% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $1.13M | +13.5% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $12.14M | -5.5% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $2.99M | n/a |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $4.06M | +14.5% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $4.05M | +12.0% |
Compare DCOY, LTRN, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗